SI-Bone Inc (NASDAQ:SIBN) CEO Jeffrey W. Dunn Sells 40,000 Shares

Share on StockTwits

SI-Bone Inc (NASDAQ:SIBN) CEO Jeffrey W. Dunn sold 40,000 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $18.51, for a total value of $740,400.00.

Shares of NASDAQ:SIBN traded up $0.07 during midday trading on Friday, reaching $18.51. 281,300 shares of the company’s stock traded hands, compared to its average volume of 121,081. The company has a fifty day simple moving average of $17.32 and a two-hundred day simple moving average of $17.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 11.55 and a current ratio of 12.00. The company has a market cap of $477.76 million and a P/E ratio of -26.07. SI-Bone Inc has a 1 year low of $14.08 and a 1 year high of $23.03.

Separately, ValuEngine lowered SI-Bone from a “buy” rating to a “hold” rating in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $24.75.

Several large investors have recently modified their holdings of SIBN. First Light Asset Management LLC acquired a new stake in shares of SI-Bone during the 2nd quarter worth about $13,248,000. BlackRock Inc. increased its position in shares of SI-Bone by 70.7% during the 2nd quarter. BlackRock Inc. now owns 1,120,294 shares of the company’s stock worth $22,787,000 after purchasing an additional 463,874 shares during the last quarter. Meridian Investment Counsel Inc. acquired a new stake in shares of SI-Bone during the 2nd quarter worth about $7,813,000. Capital Bank & Trust Co acquired a new stake in shares of SI-Bone during the 2nd quarter worth about $5,249,000. Finally, Vanguard Group Inc. increased its position in shares of SI-Bone by 65.5% during the 2nd quarter. Vanguard Group Inc. now owns 563,111 shares of the company’s stock worth $11,454,000 after purchasing an additional 222,788 shares during the last quarter. 45.47% of the stock is owned by hedge funds and other institutional investors.

SI-Bone Company Profile

SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Recommended Story: Commodities

Insider Buying and Selling by Quarter for SI-Bone (NASDAQ:SIBN)

Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.